Blog
1001 Articles
Back to Normal
It took six months for Dr. Richard Dotson to get diagnosed, but after a Whipple procedure and chemo he feels back to normal.
Can AI Help Personalize Cancer Care?
PNET patient Burt Rosen experiments with AI to create a digital twin that provides insight into how he might respond to different treatments.
I’m Not Dead Yet
Long-term survivor Dr. Stephen Bigelsen knew how bad pancreatic cancer was and almost gave up, until his wife pushed him to learn more.
You’re Not Alone
Caregiver for her stage IV husband Stephen, Nancy Bigelsen credits the support of family and friends for helping them through his treatment.
The FDA Approves Rasonque™ (Daraxonrasib)
The FDA has approved Rasonque (daraxonrasib), the first drug approved to target KRAS in pancreatic cancer patients.
Could AI Help Detect the Pancreatic Cancers We Usually Miss?
Dr. Ajit Goenka is leading a team at the Mayo Clinic that is exploring how AI can be used to find random pancreatic cancer.
A Master Class in Self-Love
Wendy Hammers turned her pancreatic cancer diagnosis into life lessons for mental health, wellness, and focusing on joy.
At the Table: Looking Forward 10 Years
Members of the Patient Advisory Board discuss the changes they would like to see in 10 years in treatment, early detection, and managing care.
The Risk of a Dilated Pancreatic Duct
Dr. Mimi Canto and the team at Johns Hopkins have identified a dilated pancreatic duct as a risk factor for pancreatic cancer.
Surviving Will Someday Be the Expectation
Susan Ganis did not expect to be a survivor of pancreatic cancer, but she stayed positived and focused on the future.
The Future is Bright
The doctors and researchers at Duke Cancer Institute see a brighter future ahead for pancreatic cancer patients.
Daraxonrasib: What To Know About Common Side Effects
Oncodermatologist Dr. Ian Tattersall discusses the rash caused by the new KRAS drug daraxonrasib, and best options to manage the rash.
Tackling KRAS G12D
Dr. Leon Pappas explains the workings of the new KRAS G12D inhibitor, now in phase I/II clinical trials around the US and Australia.
No Symptoms Whatsoever
In a follow-up visit after her gallbladder was removed, Yariela Martínez’s doctors found stage I pancreatic cancer.
Pancreatic Cancer: The Newest Treatments
Learn more about daraxonrasib and other newest treatments for pancreatic cancer by watching the recording of our webinar.